From Name:
From Email:
To Name:
To Email:

Optional Message:

Risk protocol identifies patients with cancer not allergic to carboplatin, oxaliplatin

from Healio

Patients with cancer who had a history of presumed carboplatin- and oxaliplatin-induced hypersensitivity reaction did not appear allergic to the chemotherapy drugs after skin prick tests, according to retrospective study results published in Annals of Allergy, Asthma & Immunology. The risk-stratification protocol appeared to safely identify patients without allergic reaction to the drugs, allowing them to return to an outpatient setting for further treatment without desensitization. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063